{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:50:26Z","timestamp":1760982626179,"version":"build-2065373602"},"reference-count":29,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[1989,5,1]],"date-time":"1989-05-01T00:00:00Z","timestamp":609984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Parenter Enteral Nutr"],"published-print":{"date-parts":[[1989,5]]},"abstract":"<jats:p>The in vitro recovery of three different dosage forms of carbamazepine (CBZ) when dispersed in gastric or intestinal fluids, in the presence or absence of Ensure was determined. An equivalent of 1 mg of pure CBZ from Tegretol 200 mg of conventional tablets, chewtablets of Tegretol 200\u2010mg and Apo\u2010carbamazepine (200\u2010mg tablets) were dispersed in five dissolution mediums (0.5 ml of Ensure; 0.5 ml of Ensure and 1.0 ml of gastric fluid; 1.0 ml of gastric fluid; 0.5 ml of Ensure and 1.0 ml of intestinal fluid; and 1.0 ml intestinal fluid) and mixed for 1 hr and filtered. The filtrates were then assayed for CBZ using a UV spectrophotometer. The mean recoveries of CBZ for all dosage forms in the various dissolution mediums were: Ensure\/gastric fluid, 85%; gastric fluid, 75%, Ensure\/intestinal fluid, 59%; intestinal fluid, 79%; and Ensure, 58%. The differences in CBZ recovery from gastric or intestinal fluid, in the presence or absence of Ensure were found to be statistically significant (<jats:italic>p<\/jats:italic> &lt; 0.05). The difference in dosage forms were statistically not discernible. The significant differences observed in recoveries of CBZ due to Ensure warrants an in <jats:italic>vivo<\/jats:italic> study to realize the clinical implication of administering CBZ with Ensure. (<jats:italic>Journal of Parenteral and Enteral Nutrition<\/jats:italic> <jats:bold>13:<\/jats:bold>272\u2013276, 1989)<\/jats:p>","DOI":"10.1177\/0148607189013003272","type":"journal-article","created":{"date-parts":[[2008,5,14]],"date-time":"2008-05-14T19:51:26Z","timestamp":1210794686000},"page":"272-276","source":"Crossref","is-referenced-by-count":7,"title":["In Vitro Recovery of Carbamazepine from Ensure"],"prefix":"10.1002","volume":"13","author":[{"given":"Rosemin","family":"Merali Kassam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin","family":"Friesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Locock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[1989,5]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"1","volume-title":"Individualizing Drug Therapy: Practical Applications of Drug Monitoring","author":"Mackichan JJ","year":"1981"},{"key":"e_1_2_1_3_1","first-page":"448","volume-title":"Goodman and Gilman's the Pharmacological Basis of Therapeutics","author":"Rall TW","year":"1980"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-197803020-00003"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-197917060-00005"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1975176657"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/0148607183007002186"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-198311000-00008"},{"key":"e_1_2_1_9_1","first-page":"685","article-title":"Recovery of phenytoin from an enteral nutrient formula","volume":"43","author":"Hooks MA","year":"1986","journal-title":"Am J Hosp Pharm"},{"key":"e_1_2_1_10_1","first-page":"931","article-title":"Hypertonic formula resulting from added oral medications","volume":"136","author":"White KC","year":"1982","journal-title":"Am J Dis Child"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.32.5.570"},{"key":"e_1_2_1_12_1","first-page":"110","article-title":"Dietary interaction with phenytoin","volume":"3","author":"Hatton RC","year":"1984","journal-title":"Clin Pharm"},{"key":"e_1_2_1_13_1","first-page":"274","article-title":"Effect of enteral nutrition on warfarin therapy","volume":"1","author":"Parr MD","year":"1982","journal-title":"Clin Pharm"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.288.6416.557"},{"first-page":"1105","volume-title":"The National Formulary","year":"1980","key":"e_1_2_1_15_1"},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0016-5085(19)33288-3","article-title":"Diarrhea: Current view of the pathophysiology","volume":"63","author":"Phillips SF","year":"1972","journal-title":"Gastroenterology"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0160-5402(83)90048-7"},{"volume-title":"Introductory Statistics","year":"1977","author":"Wonnacott TH","key":"e_1_2_1_18_1"},{"volume-title":"Probability and Statistics for Engineers","year":"1985","author":"Miller I.","key":"e_1_2_1_19_1"},{"issue":"88","key":"e_1_2_1_20_1","first-page":"9","article-title":"Carbamazepine: Pharmacology and clinical uses","volume":"64","author":"Sillanpaa M.","year":"1981","journal-title":"Acta Neurol Scand"},{"volume-title":"Ensure Product Information Handbook","year":"1986","author":"Ross Laboratories.","key":"e_1_2_1_21_1"},{"key":"e_1_2_1_22_1","first-page":"367","volume-title":"Encyclopedia of Emulsion Technology, Vol 2","author":"Jaynes EN","year":"1985"},{"volume-title":"Practical Emulsions","year":"1968","author":"Bennett H.","key":"e_1_2_1_23_1"},{"key":"e_1_2_1_24_1","first-page":"253","volume-title":"Remington's Pharmaceutical Sciences","author":"Zografi G.","year":"1980"},{"key":"e_1_2_1_25_1","first-page":"266","volume-title":"Remington's Pharmaceutical Sciences","author":"Schott H.","year":"1980"},{"key":"e_1_2_1_26_1","first-page":"294","volume-title":"Remington's Pharmaceutical Sciences","author":"Higuchi WI","year":"1980"},{"key":"e_1_2_1_27_1","first-page":"979","volume-title":"Remington's Pharmaceutical Sciences","author":"Gibb JW","year":"1980"},{"key":"e_1_2_1_28_1","first-page":"465","volume-title":"Antiepileptic Drugs","author":"Morselli PL","year":"1982"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600681018"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600710314"}],"container-title":["Journal of Parenteral and Enteral Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aspenjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1177\/0148607189013003272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T18:57:07Z","timestamp":1760641027000},"score":1,"resource":{"primary":{"URL":"https:\/\/aspenjournals.onlinelibrary.wiley.com\/doi\/10.1177\/0148607189013003272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,5]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1989,5]]}},"alternative-id":["10.1177\/0148607189013003272"],"URL":"https:\/\/doi.org\/10.1177\/0148607189013003272","archive":["Portico"],"relation":{},"ISSN":["0148-6071","1941-2444"],"issn-type":[{"type":"print","value":"0148-6071"},{"type":"electronic","value":"1941-2444"}],"subject":[],"published":{"date-parts":[[1989,5]]}}}